SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Newlink Genetics Corporation

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading NLNK News...
Health Technology » Biotechnology
GILDGilead Sciences, Inc.
AMGNAmgen Inc.
BIIBBiogen Inc.
CELGCelgene Corporation
ILMNIllumina, Inc.
REGNRegeneron Pharmaceuticals, Inc.
SRPTSarepta Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
INCYIncyte Corporation
VRTXVertex Pharmaceuticals Incorporated
CLVSClovis Oncology, Inc.
EXELExelixis, Inc.
BMRNBioMarin Pharmaceutical Inc.

Company Profile

NewLink Genetics Corp. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.